FDA Inspection 1105852 — GraftSource, LLC
The FDA completed an inspection of GraftSource, LLC on September 19, 2019 in Grapevine, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 19, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Grapevine, TX (United States)